Opportunities and limitations of drug-coated balloons in interventional therapies

Herz

Volumn 36, Issue 3, 2011, Pages 232-240

  Scheller, B ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Drug coated balloon; Drug eluting balloon; Local drug delivery; Paclitaxel; Restenosis

Indexed keywords

CHROMIUM; COBALT; PACLITAXEL; SHELLAC;

ARTERY DISSECTION; ARTICLE; BALLOON CATHETER; BARE METAL STENT; CLINICAL EFFECTIVENESS; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DEVICE SAFETY; DISEASE SEVERITY; DOSE RESPONSE; DRUG ELUTING STENT; DRUG MEGADOSE; DRUG TOLERABILITY; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; INTERVENTION STUDY; LEG ISCHEMIA; MATERIAL COATING; NONHUMAN; OUTCOME ASSESSMENT; PERIPHERAL OCCLUSIVE ARTERY DISEASE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT PLANNING;

BALLOON DILATION; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FIBRINOLYTIC AGENTS; FORECASTING; HEART CATHETERIZATION; HUMANS;

EID: 79959773007     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-011-3462-3     Document Type: Article

References (39)

1. Gruntzig A (1978) Transluminal dilatation of coronary-artery stenosis. Lancet 1(8058):263
2. Sigwart U et al (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 316(12):701-706 (Pubitemid 17036474)
3. Morice MC et al (2002) A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346(23):1773-1780
4. Scheller B et al (2006) Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 355(20):2113-2124 (Pubitemid 44749319)
5. Hwang CW, Wu D, Edelman ER (2001) Physiological transport forces govern drug distribution for stent-based delivery. Circulation 104(5):600-605 (Pubitemid 32738132)
6. Scheller B, Speck U, Bohm M (2007) Prevention of restenosis: is angioplasty the answer? Heart 93(5):539-541
7. Axel DI et al (1997) Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 96(2):636-645 (Pubitemid 27329445)
8. Scheller B et al (2003) Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur Heart J 24(15):1462-1467
9. Scheller B et al (2003) Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. J Am Coll Cardiol 42(8):1415-1420 (Pubitemid 37267283)
10. Iofina E et al (2006) Polymer-based paclitaxel-eluting stents are superior to nonpolymer-based paclitaxel-eluting stents in the treatment of de novo coronary lesions. Am J Cardiol 98(8):1022-1027 (Pubitemid 44486136)
11. Joner M et al (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48(1):193-202 (Pubitemid 43929240)
12. Virmani R et al (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus- eluting stent: should we be cautious? Circulation 109(6):701-705
13. Creel CJ, Lovich MA, Edelman ER (2000) Arterial paclitaxel distribution and deposition. Circ Res 86(8):879-884 (Pubitemid 30246985)
14. Lovich MA et al (2001) Carrier proteins determine local pharmacokinetics and arterial distribution of paclitaxel. J Pharm Sci 90(9):1324-1335 (Pubitemid 32867981)
15. Scheller B et al (2002) Acute cardiac tolerance of current contrast media and the new taxane pro-taxel using iopromide as carrier during porcine coronary angiography and stenting. Invest Radiol 37(1):29-34 (Pubitemid 34027842)
16. Speck U et al (2004) Inhibition of restenosis in stented porcine coronary arteries: uptake of paclitaxel from angiographic contrast media. Invest Radiol 39(3):182-186 (Pubitemid 38263924)
17. Scheller B et al (2004) Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110(7):810-814 (Pubitemid 39096008)
18. Speck U et al (2006) Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 240(2):411-418 (Pubitemid 44098636)
19. Albrecht T et al (2007) Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine. Invest Radiol 42(8):579-585 (Pubitemid 47051835)
20. Cremers B et al (2009) Drug-eluting balloon: very short-term exposure and overlapping. Thromb Haemost 101(1):201-206
21. Schnorr B et al (2010) Paclitaxel-coated balloons - survey of preclinical data. Minerva Cardioangiol 58(5):567-582
22. Kelsch B et al (2011) Dose response to paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model. Invest Radiol (in press)
23. Posa A et al (2008) Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries. Coron Artery Dis 19(4):243-247
24. Cremers B et al (2009) Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model. Clin Res Cardiol 98(5):325-330
25. Posa A et al (2010) Optimization of drug-eluting balloon use for safety and efficacy: evaluation of the 2nd generation paclitaxel-eluting DIOR-balloon in porcine coronary arteries. Catheter Cardiovasc Interv 76(3):395-403
26. Scheller B et al (2008) Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol 97(10):773-781
27. Unverdorben M et al (2009) Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 119(23):2986-2994
28. Wijns W et al (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 31(20):2501-2555
29. Unverdorben M et al (2010) Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 99(3):165-174
30. Poss J et al (2010) Hotlines and clinical trial updates presented at the German Cardiac Society Meeting 2010: FAIR-HF, CIPAMI, LIPSIA-NSTEMI, Handheld-BNP, PEPCAD III, remote ischaemic conditioning, CERTIFY, PreSCD-II, German Myocardial Infarction Registry, DiaRegis. Clin Res cardiol 99(7):411-417
31. Mathey DKFX (2011) Treatment of bifurcation lesions with a drug-eluting balloon. EuroIntervention Supplement (in press)
32. Kleber FXMD, Rittger H, Scheller B (2011) On behalf of the German drug-eluting balloon consensus group. How to use the drug-eluting balloon. Recommendations by the German consensus group. EuroIntervention Supplement (in press)
33. Cortese B et al (2010) Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart 96(16):1291-1296
34. Fanggiday JC et al (2008) Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry. Catheter Cardiovasc Interv 71(5):629-635 (Pubitemid 351559549)
35. Belkacemi AA, Voskuil P, Stella MP (2011) Coronary bifurcation lesions treated with drug-eluting balloon: results of the DEBIUT study. EuroIntervention Supplement (in press)
36. Cremers B et al (2010) Treatment of coronary in-stent restenosis with a novel paclitaxel urea coated balloon. Minerva Cardioangiol 58(5):583-588
37. Werk M et al (2008) Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 118(13):1358-1365
38. Tepe G et al (2008) Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 358(7):689-699 (Pubitemid 351240748)
39. Fokstuen S et al (2011) Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practice. J Med Genet (in press)